5.4 HELLP Syndrome & Hepatic Crisis Management
Key Takeaways
- HELLP syndrome is a severe variant of preeclampsia characterized by microangiopathic hemolytic anemia, elevated liver enzymes, and low platelets; the gold-standard Tennessee criteria mandate: Hemolysis (schistocytes on blood smear, LDH >600 IU/L, total bilirubin >=1.2 mg/dL), Elevated Liver enzymes (AST >=70 IU/L), and Low Platelets (<100,000/mcL).
- The Mississippi Triple-Class system stratifies disease severity and maternal-fetal risk based on platelet nadir: Class 1 (<50,000/mcL; highest mortality and bleeding risk), Class 2 (50,000 to <100,000/mcL), and Class 3 (100,000 to 150,000/mcL with LDH >600 and AST >=40).
- Hepatic subcapsular hematoma and rupture represent rare, life-threatening complications manifesting as acute-onset severe right upper quadrant/epigastric pain radiating to the right shoulder, refractory hypotension, and hypovolemic shock; immediate diagnostic evaluation requires emergent point-of-care ultrasound (FAST) or contrast CT.
- Hemodynamically stable patients with unruptured, contained subcapsular hematomas are managed non-operatively with intensive ICU surveillance, correction of coagulopathy, and serial imaging; active hepatic rupture or hemoperitoneum requires immediate damage-control surgery (perihepatic packing) or transcatheter hepatic arterial embolization (TAE).
- Platelet transfusion is indicated for active bleeding, prior to cesarean delivery if platelets are <50,000/mcL, or prior to neuraxial anesthesia if platelets are <70,000-80,000/mcL; definitive treatment is delivery, initiated without delay after maternal stabilization at >=34 weeks, or following 24-48 hours of corticosteroid stabilization between 24 and 34 weeks in the absence of maternal-fetal decompensation.
HELLP Syndrome & Hepatic Crisis Management
HELLP syndrome—an acronym for Hemolysis, Elevated Liver enzymes, and Low Platelets—is a severe, life-threatening form of preeclampsia characterized by systemic microvascular endothelial injury, platelet activation and consumption, and microvascular fibrin deposition in hepatic sinusoids. It occurs in approximately 0.5% to 0.9% of all pregnancies and in 10% to 20% of cases of preeclampsia with severe features. HELLP syndrome carries substantial maternal risks, including disseminated intravascular coagulation (DIC; 20%), placental abruption (16%), acute renal failure (8%), pulmonary edema (6%), subcapsular liver hematoma/rupture (1%), and maternal mortality (1–3%).
1. Pathophysiology of Microangiopathy & Hepatic Necrosis
The central pathological driver of HELLP syndrome is widespread microvascular endothelial damage triggered by circulating placenta-derived anti-angiogenic factors:
- Microangiopathic Hemolytic Anemia (MAHA): Endothelial denudation and intravascular fibrin meshwork formation cause mechanical fragmentation of erythrocytes as they traverse narrowed, turbulent capillary beds. This shearing produces characteristic schistocytes, burr cells, and helmet cells on peripheral blood smears, releasing intracellular lactate dehydrogenase (LDH) and free hemoglobin, which binds and depletes serum haptoglobin.
- Consumptive Thrombocytopenia: Extensive endothelial repair leads to continuous platelet adhesion, aggregation, and consumption, shortening platelet lifespan and dropping platelet counts.
- Sinusoidal Fibrin Deposition & Periportal Necrosis: Fibrin thrombi deposit within hepatic sinusoids, causing sinusoidal obstruction, intrahepatic vascular congestion, elevated sinusoidal pressure, localized ischemia, and patchy periportal hepatocyte necrosis. This produces marked elevations in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
- Glisson's Capsule Distension & Subcapsular Hematoma: Continued sinusoidal bleeding dissects beneath the liver capsule, forming a subcapsular hematoma. Increased intrahepatic pressure or minimal abdominal trauma can precipitate catastrophic capsular rupture and massive hemoperitoneum.
2. Diagnostic Criteria: Tennessee vs. Mississippi Classifications
Two major diagnostic classification frameworks are utilized in clinical practice:
+---------------------------------------------------------------------------------------------------+
| TENNESSEE CRITERIA (COMPLETE / STRICT HELLP) |
| |
| 1. HEMOLYSIS (Requires at least TWO of the following): |
| • Abnormal peripheral blood smear showing schistocytes, burr cells, or helmet cells. |
| • Serum Lactate Dehydrogenase (LDH) > 600 IU/L. |
| • Total Serum Bilirubin >= 1.2 mg/dL (in the absence of underlying liver disease). |
| • Undetectable / low serum haptoglobin (<25 mg/dL). |
| |
| 2. ELEVATED LIVER ENZYMES: |
| • Serum Aspartate Aminotransferase (AST) >= 70 IU/L (or >2x upper limit of normal). |
| • Serum Alanine Aminotransferase (ALT) >= 50–70 IU/L. |
| |
| 3. LOW PLATELETS: |
| • Platelet count < 100,000 / mcL (<100 x 10^9 / L). |
| |
| * Note: Partial / Incomplete HELLP (e.g., ELLP or LP) meets 1 or 2 criteria but carries high |
| risk of progressing rapidly to complete HELLP. |
+---------------------------------------------------------------------------------------------------+
Mississippi Triple-Class System
The Mississippi classification stratifies HELLP severity based on the patient's nadir platelet count, which correlates directly with maternal morbidity, multi-organ dysfunction, and recovery trajectory:
| Mississippi Class | Platelet Nadir Threshold | Transaminase (AST/ALT) & LDH Criteria | Clinical Morbidity & Risk Profile |
|---|---|---|---|
| Class 1 (Severe / High Risk) | Platelets $<50,000\text{/mcL}$ ($<50\times 10^9\text{/L}$) | $\text{AST or ALT} \ge 70\text{ IU/L}$<br>$\text{LDH} > 600\text{ IU/L}$ | Highest risk of DIC, acute kidney injury, pulmonary edema, liver rupture, and maternal mortality. |
| Class 2 (Moderate / Intermediate) | Platelets $50,000\text{ to }<100,000\text{/mcL}$ | $\text{AST or ALT} \ge 70\text{ IU/L}$<br>$\text{LDH} > 600\text{ IU/L}$ | Moderate morbidity; requires immediate stabilization and prompt delivery. |
| Class 3 (Mild / Incipient) | Platelets $100,000\text{ to }150,000\text{/mcL}$ | $\text{AST or ALT} \ge 40\text{ IU/L}$<br>$\text{LDH} > 600\text{ IU/L}$ | Incipient HELLP; close monitoring required; high rate of escalation to Class 1/2. |
3. Differential Diagnosis of Microangiopathic & Hepatic Emergencies
HELLP syndrome frequently mimics and must be differentiated from other critical medical and hematologic disorders occurring in late pregnancy:
| Feature / Disorder | HELLP Syndrome | Acute Fatty Liver of Pregnancy (AFLP) | Thrombotic Thrombocytopenic Purpura (TTP) | Atypical Hemolytic Uremic Syndrome (aHUS) |
|---|---|---|---|---|
| Primary Pathology | Microvascular endothelial activation & sinusoidal thrombosis | Defective mitochondrial fatty acid oxidation (LCHAD deficiency) | Severe ADAMTS13 deficiency ($<10%$) leading to ultra-large vWF multimers | Uncontrolled alternative complement pathway dysregulation |
| Hypertension & Proteinuria | Present in $>85%$ of cases | Variable / Mild (present in 50%) | Variable (often absent) | Common / Severe |
| Hypoglycemia & Ammonia | Normal glucose; Normal ammonia | Profound Hypoglycemia ($<50\text{ mg/dL}$); Elevated Ammonia | Normal glucose; Normal ammonia | Normal glucose; Normal ammonia |
| Coagulopathy (PT/INR, Fibrinogen) | Normal until advanced DIC ensues | Severe early coagulopathy (Profoundly low fibrinogen, high INR) | Normal PT/INR and normal fibrinogen | Normal PT/INR; Normal fibrinogen |
| Transaminases (AST/ALT) | Moderately elevated ($100\text{--}1,000\text{ IU/L}$) | Markedly elevated ($300\text{--}1,000+\text{ IU/L}$) | Normal or minimally elevated | Normal or minimally elevated |
| Renal vs. Neurological Focus | Variable renal impairment | Acute renal failure common | Severe fluctuating neurological signs (coma, stroke, seizures) | Severe acute anuric renal failure |
| Definitive Treatment | Delivery & supportive care | Immediate delivery & ICU glucose/plasma support | Therapeutic Plasma Exchange (TPE) | Complement inhibitor (Eculizumab / Ravulizumab) |
4. Hepatic Subcapsular Hematoma & Rupture
Hepatic subcapsular hematoma and parenchymal rupture represent the most catastrophic hepatic complications of HELLP syndrome, occurring in approximately 1 in 40,000 to 1 in 250,000 pregnancies, with maternal-fetal mortality historically reaching 20% to 50%.
Clinical Presentation & The Classic Triad
- Acute Triad: Sudden, severe right upper quadrant (RUQ) or epigastric pain radiating to the right shoulder/neck (Kehr's sign due to diaphragmatic peritoneal irritation), acute abdominal distension, and rapid progression to hypovolemic shock / profound hypotension.
- Precipitating Factors: Spontaneous rupture, minor abdominal trauma, vigorous palpation, or increased intra-abdominal pressure during labor contractions or operative delivery.
+---------------------------------------------------------------------------------------------------+
| HEPATIC CRISIS EMERGENCY MANAGEMENT PATHWAY |
| |
| 1. IMMEDIATE DIAGNOSTIC IMAGING: |
| • Bedside Point-of-Care Ultrasound (POCUS / FAST Exam): Immediate bedside detection of free |
| fluid (hemoperitoneum) in Morison's pouch and the pelvis. |
| • Contrast-Enhanced Abdominal CT: Modality of choice in hemodynamically STABILIZED patients |
| to delineate hematoma size, parenchymal depth, and active arterial extravasation ("blush"). |
| |
| 2. HEMODYNAMIC RESUSCITATION & COAGULOPATHY CORRECTION: |
| • Activate Massive Transfusion Protocol (MTP; 1:1:1 ratio PRBCs, FFP, Platelets). |
| • Administer IV Cryoprecipitate if Fibrinogen <150–200 mg/dL. |
| • Initiate IV Magnesium Sulfate for seizure prophylaxis and neuroprotection. |
| |
| 3. STABLE CONTAINED HEMATOMA (UNRUPTURED CAPSULE): |
| • Non-operative management in Surgical/Obstetric ICU. |
| • Strict bed rest; serial hematocrits and coagulation labs every 2–4 hours. |
| • STRICT AVOIDANCE OF ABDOMINAL PALPATION, LEOPOLD MANEUVERS, OR FUNDAL PRESSURE. |
| |
| 4. ACTIVE EXTRAVASATION / HEMODYNAMICALLY STABLE: |
| • Transcatheter Hepatic Arterial Embolization (TAE) by Interventional Radiology (IR). |
| |
| 5. ACTIVE RUPTURE / HEMODYNAMIC COLLAPSE / HEMOPERITONEUM: |
| • Immediate Emergency Damage-Control Laparotomy with Trauma / Hepatobiliary Surgery. |
| • Perihepatic surgical packing (4 quadrants), topical hemostatics (fibrin sealants, thrombin),|
| temporary abdominal closure (open abdomen / negative pressure therapy). |
| • Pringle maneuver (cross-clamping hepatoduodenal ligament) to control inflow bleeding. |
| • Liver Transplantation evaluation if parenchymal necrosis is extensive or liver fails. |
+---------------------------------------------------------------------------------------------------+
5. Platelet Transfusion Thresholds & Neuraxial Anesthesia Safety
Thrombocytopenia in HELLP syndrome requires clear, protocolized transfusion thresholds before operative interventions:
+---------------------------------------------------------------------------------------------------+
| HELLP SYNDROME PLATELET TRANSFUSION GUIDELINES |
| |
| • VAGINAL DELIVERY: |
| Transfusion generally not required unless active bleeding is present or count <20,000/mcL. |
| |
| • CESAREAN DELIVERY: |
| Transfuse 1 apheresis unit of platelets (or 6 pooled units) if count is <50,000/mcL |
| immediately prior to skin incision (target count >=50,000/mcL for surgical hemostasis). |
| |
| • NEURAXIAL ANESTHESIA (SPINAL / EPIDURAL): |
| • Platelets >= 70,000–80,000/mcL: Generally acceptable for neuraxial placement in the absence |
| of rapidly falling counts or platelet dysfunction. |
| • Platelets < 70,000/mcL: Neuraxial anesthesia is CONTRAINDICATED due to the catastrophic risk |
| of epidural/spinal hematoma and permanent spinal cord compression. General anesthesia is |
| the method of choice. |
+---------------------------------------------------------------------------------------------------+
6. Obstetric Delivery Timing & Corticosteroid Protocols
- Definitive Treatment: Delivery of the fetus and placenta is the only definitive resolution of HELLP syndrome.
- Gestational Age Stratification:
- $\ge 34\text{ 0/7 weeks}$ of Gestation: Delivery is indicated immediately following maternal hemodynamic and hematologic stabilization.
- $<34\text{ 0/7 weeks}$ of Gestation: If maternal and fetal status remain stable, delivery may be deferred for 24 to 48 hours to allow completion of a course of antenatal corticosteroids (Betamethasone 12 mg IM Q24H x 2 doses) for fetal lung maturity and neonatal organ protection.
- Immediate Delivery regardless of Gestational Age: Mandatory if any of the following occur: DIC, multiorgan failure, renal failure, liver hematoma/rupture, placental abruption, eclampsia, or non-reassuring fetal status.
- Postpartum Course: Platelet counts typically reach their nadir at 24 to 48 hours postpartum, followed by spontaneous recovery and normalization by postpartum day 4 to 6. Transaminases and LDH usually peak within 24 to 48 hours postpartum and steadily decline.
A 27-year-old G1P0 at 33 weeks of gestation presents with severe right upper quadrant pain, nausea, and headache. Laboratory results show: hemoglobin 9.2 g/dL, platelet count 42,000/mcL, AST 210 IU/L, ALT 185 IU/L, LDH 890 IU/L, total bilirubin 1.6 mg/dL, and peripheral smear demonstrating numerous schistocytes. According to both the Tennessee and Mississippi criteria, what is the definitive diagnosis and classification?
A 35-year-old G2P1 at 32 weeks of gestation with known HELLP syndrome suddenly complains of excruciating, tearing right upper quadrant and epigastric pain that radiates to her right shoulder. Within minutes, her blood pressure drops from 158/96 mmHg to 74/42 mmHg, her heart rate surges to 134 bpm, and her abdomen becomes tense and distended. What catastrophic complication must be suspected, and what is the immediate management priority?
A 29-year-old G1P0 at 36 weeks of gestation with severe HELLP syndrome is scheduled for an urgent cesarean delivery due to persistent non-reassuring fetal heart rate decelerations. Her preoperative laboratory results reveal a platelet count of 34,000/mcL, fibrinogen 240 mg/dL, and normal PT/INR. What are the appropriate platelet transfusion and anesthetic management plans?
A 31-year-old G1P0 at 36 weeks of gestation presents with jaundice, severe nausea, vomiting, polydipsia, and lethargy. Laboratory evaluation reveals: AST 420 IU/L, ALT 460 IU/L, total bilirubin 6.8 mg/dL, platelet count 110,000/mcL, serum glucose 38 mg/dL, serum ammonia 95 mcmol/L, fibrinogen 85 mg/dL, and INR 2.4. How does this clinical presentation distinguish Acute Fatty Liver of Pregnancy (AFLP) from HELLP syndrome?